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Mouse studies have been instrumental in forming our
current understanding of early cell-lineage decisions;
however, similar insights into the early human devel-
opment are severely limited. Here, we present a
comprehensive transcriptional map of human em-
bryo development, including the sequenced tran-
scriptomes of 1,529 individual cells from 88 human
preimplantation embryos. These data show that cells
undergo an intermediate state of co-expression of
lineage-specific genes, followed by a concurrent
establishment of the trophectoderm, epiblast, and
primitive endoderm lineages, which coincide with
blastocyst formation. Female cells of all three line-
ages achieve dosage compensation of X chromo-
some RNA levels prior to implantation. However, in
contrast to the mouse, XIST is transcribed from
both alleles throughout the progression of this
expression dampening, and X chromosome genes
maintain biallelic expression while dosage compen-
sation proceeds. We envision broad utility of this
transcriptional atlas in future studies on human
development as well as in stem cell research.
INTRODUCTION
During the first 7 days of human development, the zygote
undergoes cellular division and establishes the first three distinct
cell types of the mature blastocyst: trophectoderm (TE), primi-
tive endoderm (PE), and epiblast (EPI) (Cockburn and Rossant,
2010). Although the molecular control underlying the formation
of these lineages has been extensively explored in animal
models, our knowledge of this process in the human embryo is
rudimentary. In recent years, a limited number of studies have
focused on translating conclusions from animal model systems1012 Cell 165, 1012–1026, May 5, 2016 ª 2016 The Authors. Publish
This is an open access article under the CC BY license (http://creativeto the human, providing many insights, but also revealing crucial
species differences in the transcriptional and spatio-temporal
regulation of lineage markers (van den Berg et al., 2011; Blakeley
et al., 2015; Kunath et al., 2014; Niakan and Eggan, 2013), cell
signaling responses (Kuijk et al., 2012; Roode et al., 2012; Yama-
naka et al., 2010), as well as X chromosome inactivation (XCI)
(Okamoto et al., 2011), thereby highlighting the need for studies
of the human embryo.
In mouse, the TE and the inner cell mass (ICM) segregate first,
and this is controlled by the opposing transcription factors
caudal type homeobox 2 (CDX2) and POU domain class 5 tran-
scription factor 1 (POU5F1, also known as OCTCT3/4) (Niwa
et al., 2005). Cdx2 is expressed ubiquitously at the 8-cell stage
and then restricted to the outer cells of the 16-cell morula and
the early 32-cell blastocyst. CDX2 repress POU5F1 expression
in these outer cells, driving specification and maturation of the
TE and ICM (Niwa et al., 2005). In the human, however, CDX2
protein is not expressed in the outer cells of the morula, but is
only detected in the established blastocyst and coincides with
POU5F1 in TE cells; thereby raising questions on the degree of
conservation between themouse and human TE-ICMmaturation
control mechanisms (van den Berg et al., 2011; Niakan and Eg-
gan, 2013). Comparative studies on mouse, cattle, and human
further suggest that the regulatory elements of Pou5f1 diverged
during mammalian evolution (van den Berg et al., 2011).
Further, it remains unclear when and how the divergence of the
ICM into pluripotent EPI and PE occurs in human. Studies using
antibody staining for lineage markers, such as NANOG, GATA4/
6, and SOX17, encircled a rather wide range for this split; either
coinciding with the blastocyst formation at embryonic day 5 (E5),
or occurring during the late blastocyst stage at E7, just prior to
implantation (Kuijk et al., 2012; Niakan and Eggan, 2013; Roode
et al., 2012).
Another elusive facet of early human development is X chro-
mosome dosage compensation. Eutherian mammals achieve
X gene dose balance between females (XX) and males (XY) by
transcriptional silencing of one X chromosome in female cells
(Lyon, 1961). Failure to accomplish dosage compensationed by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. Single-Cell RNA-Seq Transcriptome Profiling of Human
Preimplantation Embryos
(A) Left: quality of single-cell RNA-seq experiments assessed as nearest-
neighbor similarities between cells (maximum Spearman correlation per cell,
using all cell-pairs and all genes). Right: histogram of the number of expressed
genes per cell. Genes with RPKM R1 were considered expressed. The his-
tograms were smoothed using a Gaussian kernel.
(B) Number of embryos and cells per embryonic day (E3–E7) retained after
quality filtering.
(C) Expression-level boxplots for ubiquitously expressed Y chromosome
genes in male cells, normalized to the median in stage E4–E7. p value, two-
sided MWW.
(D) Boxplots showing the fraction transcribed SNPs detected as biallelically ex-
pressed inmalecells, shown for chromosomeXand 1.p value, two-sidedMWW.results in embryonic lethality (Goto and Takagi, 1998, 2000). In
mouse, imprinted inactivation of the paternal X chromosome
initiates around the 4-cell stage (Deng et al., 2014a; Heard
et al., 2004) and ismediated by cis coating of the silenced X chro-
mosome with the long non-coding RNA (lncRNA) Xist (Clemson
et al., 1998). The paternal X chromosome is thereafter kept inac-
tivated in the TE and PE lineages, while reactivation and a round
of random XCI takes place in the pre- and peri-implantation
stage epiblast (Heard et al., 2004; Monk and Harper, 1979; Oka-
moto et al., 2004; Takagi and Sasaki, 1975). In contrast to the
mouse, XCI is not imprinted in the human placenta (Moreira de
Mello et al., 2010), which is a TE-derived tissue. Furthermore,
the prevailing view is that human XCI does not take place until
after implantation, or at least beyond the late blastocyst stage
(Deng et al., 2014b), since RNA-FISH on X-linked genes,
including XIST, show biallelic expression in most female TE
and ICM blastomeres, even as late as E7 (Okamoto et al.,
2011). Still, many aspects of the preimplantation regulation of
the human X chromosome remain unexplored, as the available
data rely mainly on allelic analyses of a few individual genes
and direct assessments of female and male expression levels
were previously not feasible.
Using single-cell RNA sequencing (RNA-seq) technology,
we now provide a comprehensive resource, characterizing the
transcriptional dynamics of progressive lineage specification
and reveal X chromosome dosage compensation in the human
preimplantation embryo.
RESULTS
Single-Cell RNA-Seq Transcriptome Profiling of Human
Preimplantation Embryos
To obtain a transcriptional map of the human preimplantation
development, we sequenced the transcriptomes of individual
cells isolated from embryos ranging from the 8-cell stage up to
the time-point just prior to implantation. After quality control,
we retained 1,529 high-quality single-cell transcriptomes from
88 embryos, with an average of 8,500 expressed genes (reads
per kilobase of transcript per million mapped reads [RPKM]
R1; Spearman’s rR0.63; Figure 1A). A total of 13 to 24 embryos
and 81 to 466 cells were analyzed per embryonic day (Figure 1B).
To determine the sex of each embryo, we assessed the expres-
sion level of Y-linked genes for each cell (Figure S1).
To first study the maternal to zygotic transition, we assessed
the activity of ubiquitously expressed Y chromosome genes
(i.e., genes exclusively derived from the paternal germline) and
found an increase between E3 and E4 (Figure 1C; p = 8.7e22,
Mann-Whitney-Wilcoxon test [MWW]). Furthermore, by detection(E) Two-dimensional t-SNE representation of 1,529 single-cell preimplantation
transcriptomes using the 500most variable genes across all cells (according to
Figures S2A and S2B). E3–E7 indicate the embryonic day and E4.late and
E5.early indicate cells picked 4–6 hr later and earlier, respectively, than the
other cells from that embryonic day.
(F) A pseudo-time was assigned to each cell by fitting a principal curve to the
cells in the two-dimensional t-SNE subspace (Figure 1E). ICM cells were
excluded from the fit to let the principal curve better reflect time and minimize
lineage-effects (Supplemental Experimental Procedures).
See also Figures S1 and S2.
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of single nucleotide polymorphisms (SNPs) in the single-cell RNA-
seq reads, we observed that most male E3 cells contained
biallelically derivedRNAofX chromosomegenes (Figure 1D), indi-
cating the presence of lingeringmaternal transcripts. This biallelic
signal was devoid in E4 and later stages (Figures 1D, S1H, and
S1I), suggesting that maternal RNA clearance had occurred.
Thus, our data point to incomplete zygotic genome activation
(ZGA) at E3 that approaches completion by E4, in line with previ-
ous studies (Yan et al., 2013).
In order to explore the data in an unbiased manner, we carried
out dimensionality reduction using the most variable genes
across all cells, accounting for the mean-variance relationship
present in single-cell RNA-seq gene expression data (Brennecke
et al., 2013) (Figures S2A and S2B). We found that regardless of
dimensionality reduction technique used, the primary segre-
gating factor was developmental time, as cells were clearly or-
dered in agreement with embryonic day when projected onto
the first dimensionality-reduced components (Figures 1E, S2C,
and S2D). To further refine the resolution of the developmental
timing of each individual cell, we fitted a principal curve (Hastie
and Stuetzle, 1989) to the cells in a t-distributed stochastic
neighbor embedding (t-SNE) subspace (van der Maaten and
Hinton, 2008) (Figure 1F) and assigned a pseudo-time to each
cell based on its projection onto this curve, which we utilized in
parts of the temporal analysis.
Segregation of ICM and TE Appears at E5
The second strongest segregating factor emerged during E5,
where the spread between cells sharply increased, perpendic-
ular to the developmental time axis (Figure 2A). This coincided
with the time of blastocoel formation, indicating that this time
period is critical for the formation of a blastocyst and the emer-
gence of lineages. In order to identify lineages, we applied prin-
cipal component analyses (PCA) and clustering using the most
variable genes (Figure 2B; Supplemental Experimental Proce-
dures). The separation of cells along principal component 1
(PC1) corresponded to the TE and ICM segregation since the
genes with the strongest loadings on PC1 were well-known TE
lineage markers (GATA2 and GATA3) as well as known ICMFigure 2. Lineage Segregation of Cells into Inner Cell Mass, Trophecto
(A) t-SNE plot of all cells, as in Figure 1E, showing ICM and TE assignment of ce
sification was done using PAM clustering in a PCA dimensionality-reduced sub-
(B) PCA biplot showing ICM and TE classification of cells from E5. Cells were cla
space with the 250 most variable genes across all non-pre-lineage E5 cells as inp
time <12.5 were assigned as pre-lineage. Genes with high PC loadings are show
lineage markers using weights 1 and 1 for ICM and TE genes, respectively.
(C) Heatmap of E5 cells and the top 500 differentially expressed genes betwee
indicates embryo membership, lower bar indicates lineage. Right-hand-side bars
for each gene and embryonic day (E5–E7).
(D) PCA biplot showing EPI and PE classification of ICM cells from E5. Cells were c
space with the 250 most variable genes across all ICM cells that belonged to th
Procedures). Genes with high PC loadings are shown. Colors indicate the weighte
EPI and PE genes, respectively.
(E) Heatmap of E5 cells and the top 200 differentially expressed genes between
dicates embryo membership, lower bar indicates lineage. Right-hand-side bars i
for each gene and embryonic day (E5–E7).
(F) Number of cells (upper table) and lineage-specific genes (lower table) per emb
endoderm.
See also Figure S3 and Tables S1 and S2.markers (SOX2 and PDGFRA). Importantly, these TE and ICM
genes were identified as top-genes using an unbiased data-
driven approach, starting with 15,633 expressed genes. The
same procedure was then applied to E6 and E7 cells to classify
the lineage fate of the cells as ICMor TE (Figure S3). Interestingly,
applying the same unbiased approach separately to E3, E4,
and to only immature E5 cells (those marked as pre-lineage in
Figure 2A), no groupings of cells were identified. Similarly, we
observed no grouping among these cells when using previously
known human and mouse markers (Blakeley et al., 2015; Guo
et al., 2010; Yan et al., 2013) nor when using lineage-specific
genes identified in this study.
Once cells had been designated as TE or ICM, we performed
differential expression analysis between the lineages. The differ-
ential expression analysis identified 2,414 genes that were signif-
icantly differentially expressed between E5 ICM and TE cells
(false discovery rate [FDR]%5%); and 2,383 and 3,053 differen-
tially expressed genes in E6 and E7, respectively (Table S1).
Selecting the top 500 differentially expressed genes, we found
that E5 cells (excluding the immature E5 cells) segregated into
three groups (Figure 2C). Two of these groups distinctly ex-
pressed either TE or ICM genes in a mutually-exclusive manner,
indicating more matured TE and ICM lineages, whereas the third
group of cells co-expressed TE and ICM genes but at a lower
expression level. Based on this, we denoted the co-expressing
cluster of cells as E5.mid (since these cells seemed uncommitted
to a particular lineage) and labeled the other two distinct groups
as either TE or ICM and denoted them as E5.late. Further, ICM
and TE genes identified at E5 tended to maintain their lineage
specificity throughout the remainder of the preimplantation
development, as their ICM versus TE fold-changes were consis-
tent from E5 to E7, despite that E6 and E7 lineage assignment
was done independently of the E5 gene set (right-hand side
bars in Figure 2C).
Segregation of ICM into EPI and PE Appears among E5
ICM Cells
To identify EPI and PE cells, we performed a similar analysis as
described above, using the most variable genes within the ICMderm, Epiblast, and Primitive Endoderm
lls. Cells from E5 are highlighted in the lower left insert. The ICM-TE cell clas-
space (Figure 2B and Supplemental Experimental Procedures).
ssified as ICM or TE using PAM clustering in the PCA dimensionality-reduced
ut (Supplemental Experimental Procedures). Cells in embryos with a pseudo-
n. Colors indicate the weighted mean of the expression of previously known
n ICM and TE E5 cells (top 250 genes from each lineage). Upper colored bar
indicate the log2 fold-change of the TE divided by ICM mean-expression level
lassified as EPI or PE using PAM clustering in the PCA dimensionality-reduced
e right-most hierarchical cell-cluster in Figure 2C (Supplemental Experimental
d mean of the expression of known lineage markers using weights1 and 1 for
EPI and PE E5 cells (top 100 genes from each lineage). Upper colored bar in-
ndicate the log2 fold-change of the PE divided with EPI mean-expression level
ryonic day (E5–E7) and lineage. TE, trophectoderm; EPI, epiblast; PE, primitive
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cells for each embryonic day (Figures 2 and S3). Surprisingly,
along the second PC, we found ICM cells as early as E5
separated with respect to EPI and PE lineage-specificity (Fig-
ure 2D). Among the genes with the highest PC loadings were
pluripotency-related genes and known EPI markers (SOX2,
TDGF1, DPPA5, GDF3, and PRDM14), and among the genes
with the most negative PC loadings were genes implicated
in endoderm specification (PDGFRA, FGFR2, LAMA4, and
HNF1B). Differential expression analysis between the EPI and
PE cells identified 43, 1,412, and 542 differentially expressed
genes at E5, E6, and E7, respectively (FDR %5%; Table S1).
Furthermore, differentially expressed genes found in E5 main-
tained their EPI and PE specificity in E6 and E7 (Figure 2E).
The number of cells per lineage and embryonic day resulting
from the lineage classification is summarized in Figure 2F.
Lineage-Specific Genes Relate to Cell Fate
Functionality
To find lineage-specific genes, we combined the Z scores ob-
tained from the differential expression analysis of one lineage
against each of the other two (Stouffer’s method; FDR %5%;
Figure 2F; Table S1). Next, to find genes that maintain their line-
age-specificity from E5 to E7, we combined the lineage-specific
results across embryonic days, which resulted in 439, 820, and
222 significantly maintained TE-, EPI-, and PE-specific genes,
respectively (Stouffer’s method; FDR %5%; Figure 2F; Table
S2). The top-ranked maintained EPI genes exhibited expression
patterns clearly specific for cells of the EPI lineage in E6 and E7
whereas in E5 the EPI geneswere to some extent also expressed
in PE cells (Figures 3A and 3B). Top-rankedmaintained PE genes
were specifically expressed across E5 to E7, and TE genes had
low expression in E3 and E4 but were expressed in all cells
from E5 to E7, although at a higher expression level in TE
cells (Figures 3A and 3B). Several known TE markers, such as
GATA3, DAB2, and GATA2 were among the top-ranked genes
(rank 2, 25, and 58, respectively). Interestingly, CDX2 was differ-
entially expressed, but only ranked 209th, and EOMES was not
expressed at all. In addition to known markers, several less-
described markers were identified, such as PTGES, EMP2,
TGFBR3, and PDGFA (rank 1, 4, 23, and 33). Among top-ranked
EPI-specific genes were factors implicated in embryonic preim-
plantation development in mouse or human, such as PRDM14,
GDF3, TDGF1, NODAL, SOX2, and NANOG (rank 1, 3, 9, 10,
12, and 22) and a few less-established markers, including
DPPA5, ESRG, KLF17, ARGFX, and DPPA2 (rank 2, 4, 5,Figure 3. Lineage-Specific Genes Relate to Sub-population Cell Fate
(A) RPKM expression heatmap of top 25 maintained (E5–E7) lineage-specific ge
(B) Boxplot of mean expression level with respect to top 25 maintained lineage-s
expression across genes was calculated after Z score normalization as to accou
(C) Normalized RPKM mean-expression levels and Gene Ontology gene set enric
expression of each gene was calculated per embryonic day and lineage and Z s
(D) Heatmap of top variable genes within TE cells, stratified by embryonic day. Cell
ordered by hierarchical clustering.
(E) Boxplot of TE cells with respect to their mean expression level using 129 polar T
mural classification. The mean expression across polar-specific TE genes was c
(F) Boxplot of polar versus mural expression fold-changes within each embryo.
(G) CCR7-stained embryo by immunohistochemistry (IHC) (left). Boxplot of CCR
See also Tables S3 and S4.7, 19). PE-specific genes included known factors such as
COL4A1, HNF1B, PDGFRA, GATA4 and FN1 (rank 3, 4, 7, 13,
and 15) and among highly ranked genes were also LINC00261,
FRZB, AMOTL1, and DPP4 (rank 1, 5, 6, and 14). Expression
profiles for a subset of themaintained lineagemarkers are shown
for all cells, stratified by embryo, in Figure S3I.
To explore the functional roles of lineage-specific genes, we
performed Gene Ontology (GO) gene set enrichment analyses
on the top 100 maintained lineage genes from E5 to E7 (Fig-
ure 3C; Table S3). EPI-specific genes were enriched for cell
fate specification, stem cell maintenance, and embryonic pattern
specification. PE-specific geneswere enriched for terms such as
morphogenesis of an epithelium and endoderm development.
TE-specific genes were enriched in apical plasma membrane,
cell morphogenesis involved in differentiation, and active trans-
membrane transporter activity. This is in agreement with the
notion that the TE forms an outer layer of cells that acts as a bar-
rier, preventing water and solutes from passing freely through
the paracellular space.
Subpopulations within the TE Lineage
To determine whether subpopulations were present within the
lineages, we investigated the most variable genes for each line-
age and embryonic day (Supplemental Experimental Proce-
dures). Interestingly, we found two sub-clusters of cells among
E6 and E7 TE cells (Figure 3D), and differential gene expression
analysis between the two groups of cells (Kharchenko et al.,
2014) identified 269 and 349 significantly differentially expressed
genes in E6 and E7, respectively (Table S4), of which 135 genes
overlapped between E6 and E7 (129 upregulated and 6 downre-
gulated). We identified several genes that have been previously
associated with trophoblast differentiation (Figure 3F), including
CCR7 (rank 1) (Drake et al., 2004), CYP19A1 (rank 4) (Kumar
et al., 2013), DLX5 (rank 5) (Marchand et al., 2011), ERVFRD-1
(rank 6) (Mi et al., 2000), GCM1 (rank 7) (Marchand et al.,
2011), GREM2 (rank 8) (Sudheer et al., 2012), MUC15 (rank 13)
(Marchand et al., 2011), and OVOL1 (rank 16) (Renaud et al.,
2015). At an embryo level, we found that the 129 upregulated
genes segregated the cells into two clusters consistent with
our classification (Figure 3E). These genes were significantly en-
riched in 38 GO terms, most of which were related to cell-cell
signaling including ‘‘molecular transducer activity’’ and ‘‘signal
transducer activity’’ (Table S4). The significant terms and genes
were consistent with a more differentiated polar subpopulation
of the TE cells, relying on cell-cell communication between thenes, from each lineage, across all cells.
pecific genes, from each lineage, stratified by embryo and lineage. The mean
nt for that genes can be expressed at different scales.
hment results of top 100 lineage-specific genes from each lineage. The mean
core normalized across those strata.
s were clustered by PAM-clustering in the PC1 and PC2 subspace. Geneswere
E genes that were significant in both E6 and E7, stratified by embryo and polar-
alculated after Z score normalization.
7 IHC fluorescence intensity of polar and mural cells (right; p: MWW p value).
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endometrium and the implanting polar TE of the blastocyst.
Moreover, we observed higher levels of CCR7 protein at the
polar side of the embryo (Figure 3G), in both TE and ICM cells,
supporting that the identified TE subpopulations likely reflect
polar and mural cells.
Gene Expression-Inferred Developmental Timing
Corroborates Concurrent Lineage Segregation
First, to assess temporal differences we conducted differential
gene expression analysis between embryonic time points. In
almost every contrast there were more than 1,000 significantly
differentially expressed (Figure S4A). Top genes included
DNMT3L (E3 versus E4), TE genes such as CLDN4, CLDN10,
GATA2, and SLC2A1 (E4 versus E5.pre-lineage) and CGA and
PGF, which were strongly upregulated in all three lineages
from E5 to E7 (Table S5).
To obtain a combined view of the lineage specification and
developmental state, we applied diffusion map dimensionality
reduction (Haghverdi et al., 2015) on all cells using the lineage-
specific genes. This revealed the progressive development
from E3 to early E5, followed by a split into three lineages (Fig-
ure 4A; Movie S1). To further elucidate the dynamics of the
lineage specification, we scored the degree of ICM or TE segre-
gation of all cells (as the distance to the ICM-TE decision surface)
as a function of inferred developmental time (pseudo-time)
(Figure 4B). This corroborated that the blastocyst forms distinct
transcriptional states corresponding to lineages during E5, after
which the segregation (based on lineage-specific genes) did not
further increase. The analyses also revealed that cells of E3 and
E4 embryos were more similar to the ICM than the TE, express-
ing genes that will later become specific to the ICM. We applied
the same analysis with respect to the EPI and PE lineages and
again observed a separation occurring during E5, which did
not increase over time (Figure 4C).
As a complementary approach, we investigated whether
individual genes had segregating expression levels before E5.
To this end, we calculated a gene expression variability score
within each embryo for every gene and regressed it onto embry-
onic pseudo-time (Supplemental Experimental Procedures). TheFigure 4. Developmental Progression from E3 to E7 Showing the Form
(A) Three-dimensional diffusion map representation of all cells, showing lineage as
at E5 were used as input (Supplemental Experimental Procedures). DC, diffusion
(B) Lineage segregation of all 1,529 cells with respect to ICM versus TE. Left: the
diffusion-components [DC], analogous to principal components). The black line d
cells, determined by a support vector machine (Supplemental Experimental Pr
boundary (black line in the left sub-figure). The x axis indicates pseudo-time, as de
cellular pseudo-times of the cells in that embryo. Each dot below the x axis indic
(C) As (B) but with respect to EPI versus PE.
(D) Gene-gene Pearson’s correlation matrix using the top 100 lineage-specific ge
clustering of the correlation matrix and labeled with representative genes being
(E) Heatmap of expression levels (RPKM) for E3–E5 cells using the top 100 lineage
pre-determined groups, indicated by the colored dendrogram, and clustered wit
were classified into three sub-groups based on the observed hierarchical cluste
clusters and named based on which type of cells, and at which time point, the g
(F) RPKM mean expression levels of lineage-specific gene sub-clusters as ident
dence interval across cells (B = 1,000).
(G) RPKMexpression levels of representative genes from each gene sub-cluster. V
cells (B = 1,000).
See also Figure S4, Tables S5 and S6, and Movie S1.majority of lineage-specific genes gradually increased in vari-
ability and reached their maximum at E5 or later (Figure S4B).
Furthermore, lineage-specific genes expressed already during
E4 (Figures 4D–4G, described below) also increased in variability
at E5 or later, suggesting the existence of a more homogeneous
co-expressing state followed by increasingly heterogeneous
expression.
Co-expression of Lineage Markers Precedes Matured
Lineages
To investigate the transition from morula to blastocyst in more
detail, we focused on cells from E3 to E5 and lineage-specific
genes (the top 100 differentially expressed genes in each of
the three lineages). The TE-specific genes formed three main
clusters (Figures 4D and 4E), reflecting the order at which their
expression became on par with that in mature TE cells (denoted
TE.early, TE.mid, and TE.late). Also, the PE- and EPI-specific
genes formed two main clusters each, corresponding to the
time at which they increased in expression levels (Figures 4D
and 4E). During E4, the cells tended to express early EPI genes,
corresponding to about half of the investigated EPI-specific
genes and a smaller subset of PE and TE genes. Interestingly,
during early E5 the cells had activated about half of the TE genes
(TE.early and TE.mid), while still maintaining the expression of
early EPI genes, indicative of an intermediate stage of co-
expression of lineage markers. Fewer co-expressing cells were
observed at E6 and E7, corroborating that this is indeed a cellular
state that precedes maturation of the lineages. The expression
dynamics of gene set (Figure 4F) and individual genes (Figure 4G)
over embryo stage highlighted thatmany EPI geneswere already
turned on in E3 and E4 (e.g., DPPA5, ARGFX, and SOX2),
whereas a second group of EPI genes were first turned on in
E5.mid, including FGF4, TDGF1, and NODAL.
To extend the gene-dynamics analysis, we calculated pair-
wise correlations, within each stage, between the top 300 main-
tained lineage-specific genes (Table S6). Gene pairs from the
same lineage drastically increased their correlation in the transi-
tioning from E4 to E5, and within EPI and PE gene sets, the cor-
relations gradually increased from E5 to E7, whereas betweenation of Blastocyst Lineages
signment and embryonic day, respectively. A total of 94 lineage-specific genes
component.
expression of every cell with respect to lineage-specific genes (axis represent
epicts a lineage-separating border that optimally separates the two classes of
ocedures). Right: the y axis indicates the distance from the lineage decision
termined in Figure 1F. Each embryo was assigned a time using themean of the
ates an embryo, colored by the embryonic day of sampling.
nes from each lineage. Gene-modules were determined based on hierarchical
part of the cluster.
-specific genes from each lineage. Cell groups were ordered according to their
hin their respective group (E3, E4, E5.early, E5.mid, and E5.late). E5.mid cells
rs (EPI, PE, and TE). Genes were grouped according to observed hierarchical
enes were expressed.
ified in Figure 4D. Vertical lines indicate 95% non-parametric bootstrap confi-
ertical lines indicate 95%non-parametric bootstrap confidence interval across
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Figure 5. Dosage Compensation of the X Chromosome during Preimplantation Development
(A) Distribution of Spearman correlations between gene-expression levels and embryonic day (E4–E7) in female and male cells, for genes located on the
X chromosome or autosomes. p values, two-sided MWW.
(B–E) Boxplots of female-to-male expression-level ratios of transcribed X chromosome genes, shown for all cells (B) or specific for the TE (C), EPI (D), and PE (E)
lineages. Lines intersecting the medians indicate the trend for X chromosome genes, and the green dotted lines around the 1.0-ratio similarly illustrate the
medians for autosomal genes. Values above the boxplots denote p values (two-sided MWW), either indicating a significant difference between male and female
cells from the same embryonic day (green p values; deviation from one at E3 or E4), or a significant reduction between E4 and a later embryonic day (blue
p values).
(F) Boxplots showing the distribution of cellular X chromosome RPKM sums for each sex and embryonic day, using a fixed gene set. p value, two-sided MWW.
(G) Female-to-male moving expression average along the X chromosome using a 25-nearest-genes window, shown for the stages beyond ZGA completion
(E4–E7), and the same for two autosomal chromosomes included for comparison. The ticks below the moving-average lines show the locations of expressed
genes included in the estimates, colored according to embryonic day.
(legend continued on next page)
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TE-specific genes, the correlations decreased in E6 and E7,
which may reflect the mural-polar polarization (Figure S4C).
Preimplantation Sex Differences
To investigate whether sex differences were already present
during preimplantation development, we performed differential
expression analysis between female and male cells within
embryonic day and lineages. We identified 173 differentially ex-
pressed genes (FDR %5%), out of which 58 were autosomal
(0.5% of expressed autosomal genes) (Figures S4E and S4F;
Table S7). As expected, SRYwas not expressed in any cell, indi-
cating that the sex-determination program had not yet initiated
(Figure S4G). Thirteen differentially expressed Y chromosome
genes were identified, of which nine had X-linked paralogs (Fig-
ure S4H). Several of these X-Y paralogous gene pairs had high
expression correlations (Figure S4I), suggesting conserved regu-
lation. Strikingly, the X chromosome dominated the contribution
of sex-biased genes, having 105 (27% of expressed X genes)
significantly higher expressed in female cells but only 7 (1.8%
of expressed X genes) higher in male cells, and intriguingly, there
was a clear trend of gradual decrease of the female X chromo-
some overexpression from E4 to E7 (Figure S4F).
Dosage Compensation of the X Chromosome
The large number of female and male cells provided the op-
portunity to evaluate X chromosome expression dynamics
throughout human preimplantation. Interestingly, we observed
that specifically X chromosome genes tended to become down-
regulated with time. Spearman correlations between expression
level and embryonic time were negative for most X-linked
genes in female cells, but not in male cells (Figure 5A; p =
1.3e7 female versus male, MWW) and not for autosomal genes
(p > 0.05). To further study this female-specific downregulation
of the X chromosome, we calculated female-to-male relative
expression levels for transcribed genes at each embryonic day
and cell lineage. This revealed that beyond the completion of
ZGA at E4, a stage at which female cells have two active X chro-
mosomes, X-linked genes became gradually dose compensated
in all lineages (Figures 5B–5E; p = 4.7e4 to 2.1e34, MWW).
This equilibration of female andmale expression was not a result
of transcriptional upregulation in males, since the total X chro-
mosome output per cell remained nearly constant in males but
distinctly dropped between E4 and E7 in females (Figure 5F;
p = 6.8e45, MWW). To investigate whether this dampening
of female X chromosome expression occurred chromosome-
wide, the female-to-male expression was calculated by moving
averages along the chromosome. This revealed a gradual and
X chromosome-wide dosage compensation mechanism (Fig-
ure 5G), with tendency of slightly delayed downregulation of re-
gions around the centromere and the distal q-arm. As expected,
autosomes, serving as negative controls, showed equivalent
expression in male and female cells (Figure 5G). These data
imply that X chromosome-wide dosage compensation takes(H) XIST expression-level boxplots per sex, day and lineage. p values indicat
(two-sided MWW; ‘‘ns’’ denotes not significant).
(I) The fraction of cells with XIST RNA expression above indicated thresholds, st
See also Figure S5 and Table S7.place in all three cell lineages, initiating between E4 and E5
and reaching an overall 70%–85% compensation at E7. This
is dependent on chromosomal region and whether expression-
ratios of individual genes (Figures 5B–5E) or the total X chromo-
some expression output (Figure 5F) is considered.
XIST and XACT Expression
Interestingly, X chromosome dosage compensation coincided
with an upregulation of XIST in female cells (Figures 5H and 5I).
We also detected sporadic XIST expression in male cells,
although at substantially (15-fold) lower levels (Figure 5H; p =
3.1e3 to 1.9e50, MWW). Transcription of XACT, an X-linked
lncRNA recently shown to cover XIST-free X chromosomes in
cultured human embryonic stem cells (hESCs) (Vallot et al.,
2015), was activated at E4 in both sexes, but at significantly
higher levels in females (Figures S5A and S5B; p = 2.2e5, fe-
male versus male at E4). Moreover, XACT expression was
reduced in TE cells already at E5, while its expression level
was maintained slightly longer in EPI and PE cells.
Biallelic Expression of Dose-Compensated Genes
To investigate whether the observed dosage compensation
process possessed hallmarks of XCI, we sought to investigate
the X chromosome expression at an allelic resolution. Although
parental allelic origin was not available, we could call the allelic
expression for each single nucleotide variant (SNV) present in
the Single Nucleotide Polymorphism Database (dbSNP) (Sherry
et al., 2001) within each cell, as either undetected, biallelic, or
monoallelic for the reference or alternative allele (Supplemental
Experimental Procedures). Surprisingly, the degree of biallelic
X chromosome expression in female E7 cells was similar to
that of female E4 cells, in which two X:es are active (Figure 6A;
p > 0.05, female E4 versus E7, Fisher’s exact test). The low
frequency of biallelic X chromosome SNVs in male cells verified
the accuracy in the allelic expression analysis (Figure 6A; p =
2.9e49,male E7 versus female E7, Fisher’s exact test). Further-
more, embryos carrying a SNP within the XIST gene showed
that it was biallelically expressed throughout the progression
of dosage compensation (Figures 6B and S5C–S5E). Biallelic
expression was also observed for individual X-linked genes
that are normally subjected to conventional XCI in mature
tissues, even at E7 (Figure 6B). To validate the SNP calls and
biallelic expression of X chromosome genes in female E7 cells,
we Sanger-sequenced SNP-containing sequences from the sin-
gle-cell cDNA libraries, indeed confirming the allelic pattern of
36/36 tested samples or SNPs (Figures S6A–S6D).
Moving beyond single-gene analyses, we assessed whether
the X chromosome as a whole progressed toward more mono-
allelic expression during female preimplantation development.
To do this, we determined the fraction of biallelic andmonoallelic
expression for chromosome X, as well as for autosomes in each
cell. Monoallelic detection using single-cell RNA-seq can appear
both due to transcriptional bursting as well as from technicale significant differences between male and female expression distributions
ratified by sex and stage.
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dropout of RNA molecules (Reinius and Sandberg, 2015), but
regulated monoallelic expression such as that of gradual XCI
is readily detectable (Deng et al., 2014a). Under a conventional
model of XCI (i.e., a single X chromosome becoming inacti-
vated), we therefore expected the fraction of biallelic detections
from the X chromosome to steadily decrease between E4 and E7
in female cells. In contrast, we found that the X chromosome’s
biallelic fraction did not decrease as the dose equilibration pro-
gressed, but remained similar to that of autosomes (Figure 6C).
This pattern contrasted markedly with the decreased biallelic
fraction observed in mouse (Figures S6E and S6F), utilized as a
positive control for validation of the approach, in which 60%
X inactivation is reached by the early blastocyst stage. As con-
trol of completed conventional XCI in human, we analyzed
single-cell RNA-seq libraries from primary pancreatic alpha
cells, which displayed female-to-male dosage compensation
of X chromosome-wide expression as expected (Figure S6G).
As an additional control, we analyzed in vitro cultured human
female fibroblasts. Both of these somatic cell types showed low-
ered rates of biallelic expression compared to female E7 preim-
plantation cells (p = 7.4e5 and 2.5e7, MWW; Figure 6C),
consistent with the inactivation of one X chromosome in the
somatic cells, but not in E7 preimplantation cells.
Dual XIST Clouds with Biallelic Expression of ATRX
We analyzed the localization and allelic expression pattern of
XIST in female (n = 5) andmale (n = 5) E7 embryos by strand-spe-
cific single-molecule RNA FISH. The majority of female cells
(mean 83%) had dual XIST coats and an additional 6% of cells
displayed biallelic expression with skewed coating (Figures 7A–
7C), and only6%of cells had one XIST coat. In contrast,11%
ofmale cells had an XIST coat while78%of themale cells were
XIST-negative (Figure 7C). In parallel to XIST, we included RNA
probes for the X-linked gene ATRX (Figure 7D), which is dosage
compensated at E7 (female-to-male fold-change 1.08 at E7 p >
0.05; 2.01 at E4 p = 5.4e8, MWW). Nascent-located dots indi-
cated that ATRX was biallelically expressed in female cells with
dual XIST coats (Figure 7D). To verify that ATRX was dosage
compensated, we blindly counted single-molecule ATRX specks
in female and male cells. This confirmed dosage compensation
of ATRX at E7 (median 8 and 7 molecules per cell count area in
female and male respectively, fold-change = 1.14, p > 0.05) (Fig-
ure 7E). Altogether, our single-cell RNA-seq and RNA FISH data
suggest that X chromosome dosage compensation in the humanFigure 6. Biallelic Expression of XIST and X-linked Genes
(A) Scatterplots showing allelic expression levels with the number of reads aligned
for 30 random cells from E7 or E4). SNVs with monoallelic expression lie along
X chromosome SNVs over all cells, grouped by sex and embryonic day. Chromo
(B) Allele-specific expression barplots per cell, grouped by embryo, showing the
embryos carrying the indicated SNP. Data for a SNP within XIST, as well as SNPs
reads spanning the SNP position. Biallelic expression in E7 cells was confirmed
(C) Boxplots showing the proportion of biallelic expression from the X chromoso
biallelic autosomal SNVs), shown for female and male E4–E7. Human primary p
reference, representing somatic cells with conventional XCI. Green dots indicat
mosomes (shown for chr1-3). Cells with at least 25 detected chrX SNPswere cons
the female-to-male total X chromosome-wide expression dose (median ratio of to
female and male data were available (E4 to E7 and pancreatic cells), and the sam
See also Figure S6.preimplantation embryo is accomplished by reducing the
expression of both X chromosomes, in contrast to the complete
silencing of one randomly selected X chromosome that occurs
later in development.
DISCUSSION
We generated a transcriptional resource of human preimplan-
tation development including 1,529 individual cells from 88
embryos. The inclusion of a large number of embryos per stage
will dilute out embryo-specific differences that might arise due
to embryo-specific genetic variation and abnormalities. Indeed,
the analyses of the complete dataset revealed that cellular
transcriptomes primarily segregated according to embryonic
stage, followed by segregations into lineages (TE-ICM and
EPI-PE), embryo-to-embryo variability and subpopulations (po-
lar to mural TE).
Our analyses demonstrated that the segregation of all three
lineages occurs simultaneously, given our temporal resolution,
and coincides with blastocyst formation at E5. This is in contrast
to the model developed from mouse studies where the TE and
ICM fate is initiated in a positional and cell polarization-depen-
dent manner within the morula (Cockburn and Rossant, 2010),
followed by a subsequent progressive maturation of EPI and
PE that is driven by Fgf signaling in the blastocyst (Yamanaka
et al., 2010). As human morula compaction occurs at the 16-
and not the 8-cell stage (Nikas et al., 1996), a delay in lineage
segregation is not entirely surprising and this observation is
also in agreement with a previous paper showing CDX2 expres-
sion only in the expanded human blastocyst (Niakan and Eggan,
2013). It should also be noted that human compaction is not as
prominent as in the mouse, with partial compaction occurring
in some blastomeres, further delaying the formation of distinct
inner-outer compartments. In the late E4 compacting morula
cells, a transcriptional TE program is initiated, including
increased expression of GATA3, PTGES, and PDGFA. Impor-
tantly, this transcriptional induction occurs while simultaneously
co-expressing EPI and PE genes. It is not until E5, during blasto-
cyst formation, that these co-expressed lineage genes start to
become mutually restrictive.
In addition to elucidating the dynamics of lineage specifica-
tion, our analyses identified novel and less-studied genes that
may be important for preimplantation development. For example
ARGFX, ranked as the seventh most EPI-specific gene, is ato the reference and alternative allele on the y and x axis, respectively (shown
the axes. Histograms summarize the observed allelic expression ratios of all
some 1 histograms are included for comparison.
number of reads aligned to the reference and alternative allele, using all female
located within six other X-linked genes are shown. Cells without any bar lacked
for these genes by Sanger sequencing (Figures S6A–S6D).
me (chrX) relative to that of autosomes (fraction biallelic chrX SNVs / fraction
ancreatic alpha cells and in vitro female fibroblasts are included as a control
e medians when performing the same analysis on individual autosomal chro-
idered. The panel above the boxplots, ‘‘Expression-dose equivalent,’’ indicates
tal expression in Figures 5F and S6G) for stages and cell types for which both
e for chr1-3.
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Figure 7. Single-Molecule RNA-FISH Confirmed Biallelic Expression of XIST and ATRX
(A) Single-molecule RNA-FISH of XIST shown for a female and male E7 embryo. Zoomed-in regions (right) highlight that two XIST clouds (red) were observed in
female nuclei (white, Hoechst-stained), but not in male.
(B) XIST clouds were localized at the X chromosomes (sex chromosomes were identified via DNA-FISH, staining chrX:p11.1–q11.1).
(C) Barplot with RNA-FISH XIST count statistics from 898 female cells (five embryos) and 721 male cells (five embryos), categorized by the XIST localization
pattern observed in the nucleus.
(D) Left: single-molecule RNA-FISH ofATRX and XIST in a female E7 embryo. Two stronger ATRX speckles were typically observedwithin the nuclei, positioned at
the XIST clouds. Right: DNA-FISH of chromosome X, indicating that the two stronger nuclear ATRX dots localized to the X chromosomes.
(E) Boxplots of E7 RNA-seq and RNA-FISH ATRX expression levels. RNA-FISH counts confirmed that the expression levels of ATRX in female and male were on
par (mean 8.9 and 8.0; median 8 and 7, respectively), indicating dosage compensation at E7.proposed homeobox gene where the coding region is disrupted
inmostmammalian genomes analyzed, with exception of human
(Li and Holland, 2010). LINC00261, the top ranked gene en-
riched in PE, was recently identified as a definitive endoderm-
specific lncRNA driving FOXA2 expression through recruitment
of SMAD2/3 to its promoter (Jiang et al., 2015). With LINC00261
and FOXA2 being ranked as number 1 and 34 among the PE-
specific transcripts, it is reasonable to speculate that this lncRNA
may be an important regulator of PE specification.
The extensive dataset we present here revealed that gradual
dosage compensation of the X chromosome occurred in all three
lineages during human preimplantation development with both
X copies still being actively transcribed throughout this process.
Further, the biallelic expression of XIST and other X-linked genes1024 Cell 165, 1012–1026, May 5, 2016in E7 blastomeres are consistent with the patterns of nascent
RNA stains previously obtained by RNA-FISH (Okamoto et al.,
2011) although conclusions derived solely from the allelic pat-
terns in these earlier studies may have led to an opposite stand
regarding the occurrence of dose compensation. Studies on
cultured human ESCs have generated rather divergent observa-
tions regarding their XCI status (Lessing et al., 2013), and our
data suggest that the human pluripotent ground-state should
be characterized by female cells expressing XIST and having
both X chromosomes active while still demonstrating female to
male dosage compensation.
The issue of unequal sex-chromosomedose has both emerged
and been resolved many times during evolution, using diverse
strategies (Deng et al., 2014b; Mank, 2009). Even between
mammalian taxa, there exists separate solutions to dosage
compensation (Escamilla-Del-Arenal et al., 2011), and XIST is an
exclusively eutherian invention. Intriguingly, the conventional XCI
model where one of the two X chromosomes is inactivated, as
demonstrated in the mouse (Mak et al., 2004; Okamoto et al.,
2005), does not satisfactorily explain the dynamics of X chromo-
someexpressionweobserved inhumanpreimplantationdevelop-
ment. Instead, thedatafitbetterwithamodelof an initiallydual and
partial expression dampening of the two X chromosomes. XIST
represents an obvious candidate as a mediator for this damp-
ening. However, the possibility that another system, conceivably
the evolutionary traces of a more ancient dosage compensation
mechanism, might act as a second layer of compensation in hu-
man preimplantation development should also be considered.
Finally, the transcriptional atlas of the human preimplantation
embryo we provide here has unprecedented cellular and tempo-
ral resolution and will therefore be a unique resource in future
research aiming to better understand human development and
embryonic stem cells.
EXPERIMENTAL PROCEDURES
Human embryos were obtained from two cohorts at the Huddinge Karolinska
Hospital and Carl von Linne´ Clinic with ethical approval from regional ethics
board (2012/1765-31/1). The first cohort was from preimplantation genetic
diagnosis (PGD) testing on embryonic day (E) 4 and cultured until E7
(expanded blastocyst, just prior to implantation) under standard conditions
as performed in the IVFClinic (5%CO2/5%O2 in CCMmedia (Vitrolife) covered
with Ovoil (Vitrolife). The second cohort was from frozen E2 embryos thawed
(ThawKit Cleave, VitroLife) and cultured in G-1 Plus media (VitroLife) and
from E3 in CCM media. As we are restricted to embryos cultured in vitro, we
cannot exclude potential differences with their in vivo counterparts. However,
we anticipate these differences to be relatively subtle as in vitro cultured
embryos used in infertility treatment progress and give rise to viable offspring.
Embryos were dissociated through trituration in TrypLE, (Life Technologies)
and picked with fine glass capillaries. For a subset of E5–E7 embryos, ICM
cells were enriched using immunosurgery (15 embryos). Cells were dispensed
in lysis buffer, and cDNA libraries were generated using Smart-seq2 (Picelli
et al., 2014). Briefly, following cell lysis, PolyA(+) RNA was reverse transcribed
using SuperScript II reverse transcriptase (Invitrogen) and nested primers, uti-
lizing a strand-switch reaction to add a reverse primer for the second-strand
synthesis. The cDNA was amplified by PCR (18 cycles) using KAPA HiFi Hot-
Start ReadyMix (KAPA Biosystems) and purified using magnetic beads. The
quantity and quality of the cDNA libraries were assessed using an Agilent
2100 BioAnalyzer (Agilent Technologies). cDNA (1 ng) was tagmented using
transposase Tn5 and amplified with a dual-index (i7 and i5; Illumina; 10 cycles)
and individual Nextera XT libraries were purified with magnetic beads. Indexed
sequence libraries were pooled for multiplexing (40 samples per lane), and
single-end sequencing was performed on HiSeq 2000 using TrueSeq dual-
index sequencing primers (Illumina). For further details and data analysis see
the Supplemental Experimental Procedures.
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